Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by BrokeNewbieon Jan 17, 2018 5:25pm
92 Views
Post# 27380677

RE:RE:RE:RE:Cheerleaders.

RE:RE:RE:RE:Cheerleaders.Well if acb doesn't acquire cmed, they should try for icc it's alot cheaper and could boost their production up by 150000kg of dried flower at a cost of 60cent per gram and gateway to South america
Raguu17 wrote: I think it depends on how the vote goes. Oustside the obvious win/lose I am not being a smart azz

Lets say ACB get 59.7% and according to some (I don't understand it) they need 66.6%. I think that says alot. I don't think this is good for CMED share price. I see this being worst case scenerio. 

Now lets say CMED wins by 70%. This I think would be good for CMED share price. 

A yes is good for both, imo.

A no is maybe short term bad for ACB but they haven't really slowed down on other growth. They haven't extended themselves rally that much. Risk/reward wise. Last time a group tried to push ACB around we ended up in Leduc with an 800,000sfqt facility on an interantional airport. If this fails I expect something else to come out pretty quickly. 




Bullboard Posts